# The MOCA I Study - Microvascular Obstruction with CoFI™ System Assessment

> **NCT03654573** · PHASE1 · COMPLETED · sponsor: **CorFlow Therapeutics AG** · enrollment: 73 (actual)

## Conditions studied

- STEMI - ST Elevation Myocardial Infarction
- Microvascular Obstruction

## Interventions

- **DEVICE:** CorFlow Controlled Flow Infusion System - CoFI™

## Key facts

- **NCT ID:** NCT03654573
- **Lead sponsor:** CorFlow Therapeutics AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-04
- **Primary completion:** 2024-12-18
- **Final completion:** 2024-12-18
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2025-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03654573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03654573, "The MOCA I Study - Microvascular Obstruction with CoFI™ System Assessment". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT03654573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
